How do immune cells overcome the blood-brain barrier in multiple sclerosis?

Larochelle, Catherine, Alvarez, Jorge Ivan, Prat, Alexandre·2011·FEBS Letters
DOI 10.1016/j.febslet.2011.04.066

Cites (222)

Items 201–222 of 222

  1. Blockade of Histamine H2 Receptors Attenuate Blood-Brain Barrier Permeability, Cerebral Blood Flow Disturbances, Edema Formation and Cell Reactions Following Hyperthermic Brain Injury in the Rat
    R. Patnaik, S. Mohanty, Hari Shanker Sharma · 2000 · Springer eBooks
  2. Deficient p75 low-affinity neurotrophin receptor expression does alter the composition of cellular infiltrate in experimental autoimmune encephalomyelitis in C57BL/6 mice
    Britta Küst, Ietje Mantingh-Otter, Erik Boddeke, Sjef C.V.M. Copray · 2006 · Journal of Neuroimmunology
  3. Regulation of matrix metalloproteinases and their inhibitors by interferon-β: a longitudinal study in multiple sclerosis patients
    Fabián Bernal, B Elias, HP Hartung, BC Kieseier · 2009 · Multiple Sclerosis Journal
  4. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.
    Zbigniew Stelmasiak, Maria Kozioł-Montewka, Beata Dobosz, Konrad Rejdak · 2001 · PubMed
  5. Oncostatin M regulates neural precursor activity in the adult brain
    Paul Beatus, Dhanisha J. Jhaveri, Tara L. Walker, Peter G. Lucas, Rodney L. Rietze, Helen M. Cooper, Yoshihiro Morikawa, Perry Francis Bartlett · 2011 · Developmental Neurobiology
  6. The clinical course of EAE is reflected by the dynamics of the neuroantigen-specific T cell compartment in the blood
    Stefanie Küerten, Andrea Rottlaender, Michael Rodi, V.B. Velasco, Michael Schroeter, Claudia Kaiser, Klaus Addicks, Magdalena Tary‐Lehmann, Paul Lehmann · 2010 · Clinical Immunology
  7. Cleavage of Transaldolase by Granzyme B Causes the Loss of Enzymatic Activity with Retention of Antigenicity for Multiple Sclerosis Patients
    Brian P. Niland, Gabriella Miklóssy, Katalin Bánki, William E. Biddison, Livia A Casciola-Rosen, Antony Rosen, Denis Martinvalet, Judy Lieberman, András Perl · 2010 · The Journal of Immunology
  8. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis
    Nataly Urshansky, Karin Mausner-Fainberg, Eitan Auriel, Keren Regev, Firas Farhum, Arnon Karni · 2010 · Journal of the Neurological Sciences
  9. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis
    Dagmara Maria Mirowska-Guzel · 2008 · Immunopharmacology and Immunotoxicology
  10. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system
    Henrik Toft‐Hansen, Alicia Anne Babcock, Jason Michael Millward, Trevor Owens · 2007 · Journal of Neuroinflammation
  11. Interleukin-17A and interleukin-17F mRNA expression in peripheral blood mononuclear cells of patients with multiple sclerosis.
    Zohreh Babaloo, Farhad Babaie, Mehdi Farhoodi, Mohammad Reza Aliparasti, Behzad Baradaran, Shohreh Almasi, Ahmad Hoseini · 2010 · PubMed
  12. Increased ability of peripheral blood lymphocytes to degrade laminin in multiple sclerosis
    Takeshi Oki, Shunji Takahashi, Satoshi Kuwabara, Yasumasa Yoshiyama, Masahiro Mori, Takamichi Hattori, Nobuo Suzuki · 2004 · Journal of the Neurological Sciences
  13. Identification of astrocyte-derived immune suppressor factor that induces apoptosis of autoreactive T cells
    Hideo Hara, Yusuke Nanri, Emi Tabata, Saori Mitsutake, Takeshi Tabira · 2011 · Journal of Neuroimmunology
  14. Upregulation of vascular growth factors in multiple sclerosis : correlation with MRI findings
    真真 蘇 · 2009 · Medical Entomology and Zoology
  15. Act1, Scene Brain: Astrocytes Play a Lead Role
    Jane M. Rodgers, Liang Fu Zhou, Stephen D. Miller · 2010 · Immunity
  16. Microglial oxyradical production: causes and consequences.
    Carol A. Colton · 1994 · PubMed
  17. Analysis of BAFF and TRAIL expression levels in multiple sclerosis patients: evaluation of expression under immunomodulatory therapy
    Aslı Kurne, D. Guc, Hande Canpınar, Ö. F. Aydin, Guliz Sayat, M. Yörübulut, Güneş Esendağlı, Rana Karabudak · 2010 · Acta Neurologica Scandinavica
  18. -308 G > A of TNF-α gene promoter decreases the risk of multiple sclerosis: a meta-analysis
    Yan Yang, Rulin Sun, Heng Yang, Fang Zheng, Feili Gong · 2010 · Multiple Sclerosis Journal
  19. Brain derived neurotrophic factor does not act on adult human cerebral endothelial cells
    Klemens Ruprecht, Christine Stadelmann, Vera Hummel, Oliver Klein, Wolfgang Brück, Peter Rieckmann · 2002 · Neuroscience Letters
  20. [The characteristics of the blood histamine indices and of the pathomorphological changes in the gastric mucosa of patients with multiple sclerosis].
    O O Iarosh, Kanevs'ka Sa · 1992 · PubMed
  21. WITH MULTIPLE SCLEROSIS
    Robert J. Buchanan, Miguel Ángel Zúñiga, Genny Carrillo, Bonnie J. Chakravorty, Tuula M. Tyry, R Moreau, Chunfeng Huang, Timothy L. Vollmer · 2010
  22. MCAM/CD146 Defines and Regulates the Function of a Population of Human Effector Memory Th17 Lymphocytes Subset Involved in Neuroinflammation
    Catherine Larochelle, Romain Cayrol, Hania Kébir, Igal Ifergan, Jorge Ivan Alvarez, Émilie C. Viel, Lyne Bourbonnière, Arsalan S. Haqqani, Danica B Stanimirovic, Nathalie Arbour et al. · 2010 · Clinical Immunology